A Study of FORE8394 as a Single Agent in Patients With Advanced Unresectable Solid Tumors
Clinical trial NCT02428712 · COMPLETED
Trial details
- NCT number
- NCT02428712
- Sponsor
- Fore Biotherapeutics
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-04-01
- Primary completion
- 2024-07-12
- Enrollment
- 113
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.